The rising trend of CD8+ lymphocytes in six out of seven dogs 14 days after receiving the first dose was remarkable, given that it was probably due to the release of ICOCAV15 from the tumor into the peripheral blood. The gene discussed is CD8A; the disease is neoplasm.